Background: Lung cancer is the most common cancer with the highest mortality rate. Spexin peptide acts as a potential regulatory factor in glucose and energy metabolism in this cancer type. It has been reported that TRPM2 ion channel is formed by oxidative stress and stimulates Ca2++ influx in cancer patients.
Objective: In our study, we aimed to immunohistochemically determine the activity levels of Spexin peptide and TRPM2 ion channels in lung cancer patients and to differentiate their levels according to cancer type.
Methods: To determine the effects of these peptides and ion channels in lung cancer, 30 cases with lung cancer and 30 randomised control groups were formed. The activity levels of Spexin peptide and TRPM2 ion channels in different types of lung cancer and non-cancerous groups were compared.
Results: The study examined lung cancer subtypes (Adeno Ca, SCC, and Small Cell Ca) and a control group. Spexin and TRPM2 levels were significantly higher in Adeno Ca and SCC compared to controls and Small Cell Ca. Small Cell Ca showed no significant difference from controls. No differences were found between Adeno Ca and SCC.
Conclusion: Immunoreactivity levels of these markers were found to be higher in adenocarcinoma and squamous cell lung cancer tissues than in small cell cancer and non-cancerous tissues. In conclusion, spexin and TRPM2 ion channel levels can be evaluated as a marker in adenocarcinoma and squamous cell lung cancer.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.31557/APJCP.2025.26.2.399 | DOI Listing |
Eur J Cardiothorac Surg
March 2025
Division of Thoracic Surgery, Department of Surgery, Taipei Veterans General Hospital, ; Taipei City, Taiwan.
Objectives: To assess the prognostic impact of adequate lymphadenectomy and determine the optimal nodal assessment for different clinical stages of lung cancer.
Methods: We retrospectively reviewed 1214 patients with clinical stage I-III non-small cell lung cancer who had preoperative PET/CT and curative surgery (2006-2017). Patients were categorized based on whether they had adequate [R0] or inadequate lymphadenectomy [R(un)].
Eur J Cardiothorac Surg
March 2025
Department of Cardiothoracic Surgery, NewYork-Presbyterian Hospital/Weill Cornell Medical Center, New York, NY 525 E 68 St, M-404, New York, NY 10065, USA.
Objectives: Compare oncologic outcomes between single-segment and multi-segment resections in patients with clinical stage IA1 and IA2 non-small cell lung cancer.
Methods: A retrospective review (2011-2022) was conducted using a prospectively maintained database. Patients undergoing anatomical segmentectomy for clinical stage IA ≤ 2 cm non-small cell lung cancers were included.
J Proteome Res
March 2025
Department of Radiation Oncology, The Ohio State University, Columbus, Ohio 43210, United States.
Lung cancer stands as the leading cause of cancer-related death worldwide, impacting both men and women in the United States and beyond. Radiation therapy (RT) serves as a key treatment modality for various lung malignancies. Our study aims to systematically assess the prognosis and influence of RT on metabolic reprogramming in patients diagnosed with nonsmall-cell lung cancer (NSCLC) through longitudinal metabolic profiling.
View Article and Find Full Text PDFSci Adv
March 2025
Department of Radiation Oncology, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Lung cancer exhibits altered metabolism, influencing its response to radiation. To investigate the metabolic regulation of radiation response, we conducted a comprehensive, metabolic-wide CRISPR-Cas9 loss-of-function screen using radiation as selection pressure in human non-small cell lung cancer. Lipoylation emerged as a key metabolic target for radiosensitization, with lipoyltransferase 1 (LIPT1) identified as a top hit.
View Article and Find Full Text PDFSci Adv
March 2025
School of Science and Engineering, Chinese University of Hong Kong, Shenzhen, China.
Intrabronchial delivery of therapeutic agents is critical to the treatment of respiratory diseases. Targeted delivery is demanded because of the off-target accumulation of drugs in normal lung tissues caused by inhalation and the limited motion dexterity of clinical bronchoscopes in tortuous bronchial trees. Herein, we developed microrobotic swarms consisting of magnetic hydrogel microparticles to achieve intrabronchial targeted delivery.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!